Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

TBPHTBPH
Showing 8 of 29 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in THERAVANCE BIOPHARMA INC

NORTHERN TRUST CORP holds 370,534 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $6M as of 2026-Q1. The position was increased (+12.3% shares). TBPH represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$6M

Current Shares

370,534

Total Value Change

+$2.1M

Total Shares Change

-94,433

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
370,534
+12.3%
$6M0.0%$13.96
30
2025-Q4
Decreased
329,927
-3.3%
$6.2M0.0%$18.91
0
2025-Q3
Decreased
341,306
-3.1%
$5M0.0%$14.43
0
2025-Q2
Increased
352,225
+0.8%
$3.9M0.0%$11.22
27
2025-Q1
Decreased
349,417
-10.4%
$3.1M0.0%$9.23
0
2024-Q4
Increased
389,980
+1.6%
$3.7M0.0%$9.47
27
2024-Q3
Decreased
383,782
-17.5%
$3.1M0.0%$8.10
0
2024-Q2
Decreased
464,967
-4.9%
$3.9M0.0%$8.48
0

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used